XML 21 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:        
Net loss $ (1,034,681) $ (1,184,497) $ (1,576,311) $ (3,921,428)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 9,016 8,160 10,687 11,626
Bad debt expense 6,646 758 23,244 26,771
Amortization of deferred financing costs 59,761 2,124 2,832 13,269
Amortization of beneficial conversion option 188,385 195,591
Stock issued for services 57,500 62,500 62,500
Stock options compensation 91,063 113,589 137,878 430,000
Note conversion warrant expense 137,970 137,970 2,083,328
Note offer warrant expense 54,015 97,435
Changes in operating assets and liabilities:        
Accounts receivable (204,219) (112,814) (65,713) (144,738)
Prepaid expenses and other current assets (14,338) (125,544) (104,099) (853)
Accounts payable and accrued expenses 63,275 (116,262) (24,628) 256,104
Other long-term liabilities - related parties 24,806 (12,852) (11,727) 323,315
Deferred interest expense (3,230) 23,226 21,984 32,837
Deferred revenues (103,403) (46,007) 27,267 74,195
Total adjustments 229,277 (65,152) 315,630 3,301,445
Net cash used in operating activities (805,404) (1,249,649) (1,260,681) (619,983)
Cash flows from investing activities:        
Purchases of property and equipment (14,202) (6,867) (6,867) (5,558)
Net cash used in investing activities (14,202) (6,867) (6,867) (5,558)
Cash flows from financing activities:        
Sale of Common Stock 559,285 559,285 1,209,633
Exercise of stock options 3,500 3,499
Payment of deferred financing costs (103,328) (53,029)  
Proceeds from notes payable 560,000 315,000
Proceeds from notes payable - related parties 150,000 375,000 582,000
Repayment of notes payable (268,195) (180,000) (266,573) (204,401)
Repayment of notes payable - related parties (25,114) (83,834) (92,806) (28,654)
Net cash provided by financing activities 313,363 298,951 840,376 1,558,578
Net increase (decrease) in cash (506,243) (957,565) (427,172) 933,037
Cash - beginning of period 689,946 1,117,118 1,117,118 184,081
Cash - end of period 183,703 159,553 689,946 1,117,118
Supplemental disclosure of cash flow information:        
Cash paid during the period for interest and taxes 89,071 35,808 56,702 47,633
Supplemental disclosure of non-cash financing activities:        
Accrued interest notes payable converted to equity 35,038 35,039 62,294
Accrued interest notes payable related parties converted to equity     366,484
Discount on notes payable for beneficial conversion feature 248,523 121,154 170,091
Discount on notes payable - related parties for beneficial conversion feature     144,231
Discount on notes payable - related parties for warrants 38,836
Notes payable conversion warrant expense 113,762 113,762 1,647,610
Notes payable conversion underwriting warrant expense 24,207 24,208 435,718
Notes payable converted to equity $ 135,000 135,000 225,800
Notes payable related parties converted to equity     $ 1,808,068